Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ARC Pharmaceuticals
Vancouver, British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
ARC Pharmaceuticals develops medical products targeting proliferative diseases, with an initial emphasis on preventing surgical adhesions—a major complication in many surgeries. The company holds exclusive IP in this area and also pursues treatments for rheumatoid arthritis, osteoarthritis, and psoriasis. No recent clinical results are publicly summarized; the company remains privately held and focused on R&D.
- Therapeutic areas
- DermatologyImmunologyRheumatologyOther
- Modalities
- Not explicitly stated; based on focus, likely includes small molecules and possibly biologics for proliferative diseases
- Industry
- Biotech
02
Partnerships
No major partnerships publicly disclosed as of latest data available.
Beyond the preview
Go deeper on ARC Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARC Pharmaceuticals.